December 20, 2017
NIH study uncovers clues about why common cancer drug causes hearing loss
Scientists have found a new way to explain the hearing loss caused by cisplatin, a powerful drug used to treat…
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
December 20, 2017
FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss
The U.S. Food and Drug Administration has approved Spark Therapeutics’s Luxturna (voretigene neparvovec-rzyl), a new gene therapy, to treat children and adult…
December 20, 2017
Portola Pharmaceuticals’s Bevyxxa available to patients in January 2018
U.S. Food and Drug Administration (FDA) has approved the Portola Pharmaceuticals’s Prior Approval Supplement (PAS) for Bevyxxa (betrixaban) ahead of…
December 20, 2017
Boehringer Ingelheim enters into collaboration with Roche to partner for inflammatory bowel diseases
Boehringer Ingelheim today announced a collaborative agreement with Roche, focusing on the discovery and development of orally available novel Locked…
December 20, 2017
BioMarin doses first patient in global GENEr8-1 Phase 3 study
BioMarin Pharmaceutical has dosed the first patient in the global GENEr8-1 Phase 3 study with the 6e13 vg/kg dose for…
December 19, 2017
Shire receives FDA clearance for myPKFiT
The U.S. Food and Drug Administration (FDA) has granted 510(k) marketing clearance to Shire’s myPKFiT for ADVATE, a free web-based…
December 19, 2017
Pfenex cashes $18.5 million in milestones and updates Worldwide License and Option Agreement with Jazz Pharmaceuticals
Pfenex has announced the amendment of the 2016 agreement under which Pfenex granted Jazz Pharmaceuticals worldwide rights to develop and…
December 19, 2017
Hikma nets deal with Celltrion for third biosimilar product in the MENA
Hikma Pharmaceuticals has reached a licensing agreement with South Korea-based Celltrion, Inc. and Celltrion Healthcare, Inc (Celltrion) for the first…
December 18, 2017
Sanofi and Alnylam apply to the European Medicines Agency for patisiran for the treatment of hereditary ATTR amyloidosis
Sanofi Genzyme, the specialty care global business unit of Sanofi, and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the RNAi therapeutics company,…
December 18, 2017
Allergan promotes new Executive Vice President, Global Operations
Allergan has announced that Wayne Swanton has been promoted to Executive Vice President, Global Operations following notification that Rob Stewart,…